Publications by authors named "Jonathan R Adams"

Claim this Profile
O
Oseltamivir-zanamivir combination therapy suppresses drug-resistant H1N1 influenza A viruses in the hollow fiber infection model (HFIM) system.
Camilly P Pires de Mello, George L Drusano, Jonathan R Adams, Matthew Shudt, Robert Kulawy

Eur J Pharm Sci· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy.
Ashley N Brown, George L Drusano, Jonathan R Adams, Jaime L Rodriquez, Kalyani Jambunathan

mBio· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic determinants of virological response to raltegravir in the in vitro pharmacodynamic hollow-fiber infection model system.
Ashley N Brown, Jonathan R Adams, Dodge L Baluya, George L Drusano

Antimicrob Agents Chemother· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic analysis of a serine protease inhibitor, MK-4519, against hepatitis C virus using a novel in vitro pharmacodynamic system.
Ashley N Brown, James J McSharry, Jonathan R Adams, Robert Kulawy, Richard J O Barnard

Antimicrob Agents Chemother· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of half-life on the pharmacodynamic index of zanamivir against influenza virus delineated by a mathematical model.
Ashley N Brown, Jürgen B Bulitta, James J McSharry, Qingmei Weng, Jonathan R Adams

Antimicrob Agents Chemother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zanamivir, at 600 milligrams twice daily, inhibits oseltamivir-resistant 2009 pandemic H1N1 influenza virus in an in vitro hollow-fiber infection model system.
Ashley N Brown, James J McSharry, Qingmei Weng, Jonathan R Adams, Robert Kulawy

Antimicrob Agents Chemother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis